Markets may open flat Thursday amid mixed global cues. Vedanta's demerger faces delays after government objections. Nykaa may see a ₹1,200 crore block deal. Aurobindo’s unit received EU approval for a cancer biosimilar. Avenue Supermarts' Q1 revenue rose 16%, while PVR Inox plans to add 200 screens. IOB to raise ₹4,000 crore; SBI flags RCom loan as fraud.